Vascular Endothelial Growth Factor Increased by Pulmonary Surgery Accelerates the Growth of Micrometastases in Metastatic Lung Cancer

Chest

Volumn 114, Issue 6, 1998, Pages 1668-1675

  Maniwa, Yoshimasa ^a   Okada, Masayoshi ^a   Ishii, Noboru ^a   Kiyooka, Kazue ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

Angiogenesis inhibitor; Lung metastasis; Metastatic lung cancer; Vascular endothelial growth factor; Vascular permeability factor

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; CYCLOHEXANE DERIVATIVE; ENDOTHELIAL CELL GROWTH FACTOR; FUMAGILLOL CHLOROACETYLCARBAMATE; LYMPHOKINE; O-(CHLOROACETYLCARBAMOYL)FUMAGILLOL; SESQUITERPENE; VASCULOTROPIN; VASCULOTROPIN A;

ADULT; AGED; ANIMAL; ARTICLE; BLOOD; FEMALE; HUMAN; LUNG RESECTION; LUNG TUMOR; MALE; METASTASIS; MIDDLE AGED; MORTALITY; MOUSE; MOUSE STRAIN; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE PERIOD; SURVIVAL RATE; TUMOR RECURRENCE;

ADULT; AGED; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CYCLOHEXANES; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHOKINES; MALE; MICE; MICE, INBRED STRAINS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; PNEUMONECTOMY; POSTOPERATIVE PERIOD; SESQUITERPENES; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032252634     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.6.1668     Document Type: Article

References (34)

1. Thomford NR, Wooler LB, Clagett OT. The surgical treatment of metastatic tumors in the lungs. J Thoracic Cardiovasc Surg 1965; 49:357-363
2. Mountain CF, McMurtrey MJ, Hermes KE. Surgery for pulmonary metastasis: a 20-year experience. Ann Thorac Surg 1984; 38:323-330
3. Ingbar D, Fujita T, Kishimoto S, et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 1990; 348:555-557
4. Brem H, Folkman J. Analysis of experimental antiangiogenic therapy. J Pediatr Surg 1993; 28:445-451
5. Fidler IJ. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res 1990; 50:6130-6138
6. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64:327-336
7. Gimbrone MA, Leapman SB, Cotran RS, et al. Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 1972; 136:261-276
8. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995; 1:149-153
9. Senger DR, Galli SJ, Perruzzi CA, et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1982; 219:983-985
10. Ferrara N, Henzei WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161:851-858
11. Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246:1306-1309
12. Keck PJ, Hauser SD, Krivi G, et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989; 246:1309-1312
13. Tischer E, Mitchell R, Hartman T, et al. The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991; 266:11947-11954
14. Ladoux A, Frelin C. Expression of vascular endothelial growth factor by cultured endothelial cells from brain microvessels. Biochem Biophys Res Commun 1993; 194:799-803
15. Ferrara N, Winer J, Burton T. Aortic smooth muscle cells express and secrete vascular endothelial growth factor. Growth Factors 1991; 5:141-148
16. Iijima K, Yoshikawa N, Connolly DT, et al. Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. Kidney Int 1993; 44:959-966
17. Nomura M, Yamaguchi S, Harada S, et al. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J Biol Chem 1995; 47:28316-28324
18. Shibuya M, Yamaguchi S, Yamane A, et al. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (fit) closely related to the fms family. Oncogene 1990; 5:519-524
19. De Vries C, Escobedo JA, Ueno H, et al. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992; 255:989-991
20. Terman BI, Dougher-Vermazen M, Carrion ME, et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992; 187:1579-1586
21. Millauer B, Wizigmann-Voos S, Schnurch H, et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993; 72:835-846
22. Brown LF, Yeo K, Berse B, et al. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992; 176:1375-1379
23. Walgenbach K, Gratas C, Shestak KC, et al. Ischaemia-induced expression of bFGF in normal skeletal muscle: a potential paracrine mechanism for mediating angiogenesis in ischaemic skeletal muscle. Nat Med 1995; 1:453-459
24. Miller JW, Adamis AP, Shima DS, et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 1994; 145:574-584
25. Shweiki D, Itin A, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359:843-845
26. Plate KH, Breier G, Weich HA, et al. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992; 359:845-848
27. Adair TA, Gay WJ, Montani JP. Growth regulation of the vascular system: evidence for a metabolic hypothesis. Am J Pathol 1990; 259:393-404
28. Sandner P, Wolf K, Bergmaier U, et al. Induction of VEGF and VEGF receptor gene expression by hypoxia: divergent regulation in vivo and in vitro. Kidney Int 1997; 51:448-453
29. Detmar M, Brown LF, Berse B, et al. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J Invest Dermatol 1997; 108:263-268
30. Tuder RM, Flook BE, Voelkel NF. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Fit in lungs exposed to acute or to chronic hypoxia: modulation of gene expression by nitric oxide. J Clin Invest 1995; 95:1798-1807
31. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79:315-328
32. Kusaka M, Sudo K, Fujita T, et al. Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem Biophys Res Commun 1991; 174:1070-1076
33. Abe J, Zhou W, Takuwa N, et al. A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits action of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial cells. Cancer Res 1994; 54:3407-3412
34. Yamaoka M, Yamamoto T, Masaki T, et al. Inhibition of tumor growth and metastasis of rodent tumors by angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470). Cancer Res 1993; 53:4262-4267